PolicyWinds
Topic and direction labels are AI-assisted, and each one quotes the bill text it is based on. How labels work
Texas · 89th Legislature Regular Session

SB2625 Relating to the provision of an abortion-inducing drug.

Direction

Abortion medication abortionAI label

Restricts abortion access model confidence 90%

Requires in-person physician exam and follow-up visit before and after providing abortion-inducing drugs, and bars out-of-state physicians from consulting on them, so less medication abortion access.

A person may not knowingly provide an abortion-inducing drug to a pregnant woman for the purpose of inducing an abortion in the pregnant woman or enabling another person to induce an abortion in the pregnant woman unless: (1) the person who provides the abortion-inducing drug is a physician; (2) the person is physically present in this state and personally examines the pregnant woman in person at the time the person provides the abortion-inducing medication to the pregnant woman; and (3) the provision of the abortion-inducing drug satisfies the protocol authorized by this subchapter.

✓ Quote verified word for word in the bill text

Abortion provider clinic regulationAI label

Restricts abortion access model confidence 80%

Mandates that only in-state physicians who personally examine the patient may provide abortion-inducing drugs and requires a scheduled in-person follow-up visit, so tighter regulation of medication abortion providers.

the person is physically present in this state and personally examines the pregnant woman in person at the time the person provides the abortion-inducing medication to the pregnant woman

✓ Quote verified word for word in the bill text

  1. Filed (completed)
  2. Committee
  3. Passed one chamber
  4. Passed both
  5. Governor
  6. Law

Status: Died (session ended)

Last action
2025-04-03: Referred to State Affairs
Filed
2025-03-13
Committee
State Affairs
Sponsor
Donna Campbell R, Angela Paxton R

Why the model tagged it this way: The bill amends Texas law to impose stricter in-person requirements for physicians providing abortion-inducing drugs and extends licensing rules to block out-of-state consultations on medication abortion, both of which restrict access to medication abortion and regulate providers more tightly. No other listed topics are substantively addressed.

Related bills

Sponsors

Text versions

History (4 actions)
DateChamberAction
2025-04-03SReferred to State Affairs
2025-04-03SRead first time
2025-03-13SFiled
2025-03-13SReceived by the Secretary of the Senate